Home News

Full Year 2019 results presentation

Operating income, growth figures, profitability and how our products have behaved

Wed, 26/02/2020 - 00:00 0 min
Download related document
No votes yet
 
Related
ROVI informs on the impact of Covid 19 on the company’s activities
ROVI informs on the impact of Covid 19 on the company’s activities
Laboratorios Farmacéuticos ROVI, S.A. (ROVI) reports that, since the beginning of the spread of Covid-19, the company has been executing...
6 min
02/04/2020
ROVI will donate a million surgical masks to the Ministry of Health
ROVI will donate a million surgical masks to the Ministry of Health
Since the beginning of the health crisis caused by the expansion of COVID-19, ROVI has been taking measures to ensure the continuity of its...
1 min
26/03/2020
ROVI reports operating revenue growth of 26% and EBITDA growth of 106%
ROVI reports operating revenue growth of 26% and EBITDA growth of 106%
Operating revenue increased by 26% to 381.3 million euros in 2019, mainly driven by the strength of the specialty pharmaceutical...
6 min
26/02/2020